Elagolix: Indications, Data, and Dosing.
Nov 11, 2018•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Endometriosis related pelvic pain affects approximately 8% of reproductive age women. Recently, the FDA approved a new oral GnRH antagonist for treatment of endometriosis related pelvic pain. This podcast will review the indication, data, and dosage options for this new novel medication. This podcast does not represent a specific endorsement of elagolix, and was produced without industry affiliation.
For the best experience, listen in Metacast app for iOS or Android